Ignite Creation Date:
2025-12-24 @ 5:17 PM
Ignite Modification Date:
2026-06-08 @ 3:27 PM
Study NCT ID:
NCT03043950
Status:
COMPLETED
Last Update Posted:
2024-04-24
First Post:
2017-02-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Validation of a New Prognostic Score for Adult Patients With RAS Wild-type mCRC Treated With Vectibix® and FOLFIRI or FOLFOX in First Line (VALIDATE)
Sponsor:
iOMEDICO AG
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
IOM-050341
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |